Glycated Plasma Proteins as More Sensitive Markers for Glycemic Control in Type 1 Diabetes.

作者: Lina Zhang , Qibin Zhang

DOI: 10.1002/PRCA.201900104

关键词:

摘要: Purpose Glycated hemoglobin (HbA1c) is used clinically for diagnosis and therapeutic management of diabetes. However, HbA1c reflects average blood glucose level over a long period. The aim this study to look short period, more sensitive protein markers that correlate better with glycemic level. Experimental design glycated proteome human plasma from type 1 diabetic individuals good poor (n = 20 each) control are analyzed using an online two-dimensional proteomics approach. Selected peptides further validated their potential as candidate biomarkers parallel reaction monitoring. Results 305 quantified 290 significantly increased in samples control. 76 the 88 selected have receiver operating characteristic area under curve (AUC) values greater than 0.8. Six high AUC show correlation higher fold changes between HbA1c. parent proteins half-lives shorter Conclusions clinical relevance Using advanced platform glycation analysis, identified promising sensitive, term indicators patients commonly

参考文章(62)
Nadja Schröder, Luciana Silva Figueiredo, Maria Noêmia Martins de Lima, Role of brain iron accumulation in cognitive dysfunction: evidence from animal models and human studies. Journal of Alzheimer's Disease. ,vol. 34, pp. 797- 812 ,(2013) , 10.3233/JAD-121996
Ann Smith, Russell J. McCulloh, Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders. Frontiers in Physiology. ,vol. 6, pp. 187- 187 ,(2015) , 10.3389/FPHYS.2015.00187
Juliette Fortpied, Didier Vertommen, Emile Van Schaftingen, Binding of mannose-binding lectin to fructosamines : a potential link between hyperglycaemia and complement activation in diabetes Diabetes-metabolism Research and Reviews. ,vol. 26, pp. 254- 260 ,(2010) , 10.1002/DMRR.1079
Boas Gonen, Hyman Rochman, ArthurH. Rubenstein, SoniaP. Tanega, DavidL. Horwitz, HÆMOGLOBIN A1: AN INDICATOR OF THE METABOLIC CONTROL OF DIABETIC PATIENTS The Lancet. ,vol. 310, pp. 734- 737 ,(1977) , 10.1016/S0140-6736(77)90237-9
Qibin Zhang, Athena A. Schepmoes, Jonathan W. C. Brock, Si Wu, Ronald J. Moore, Samuel O. Purvine, John W. Baynes, Richard D. Smith, Thomas O. Metz, Improved methods for the enrichment and analysis of glycated peptides. Analytical Chemistry. ,vol. 80, pp. 9822- 9829 ,(2008) , 10.1021/AC801704J
Andrej Frolov, Matthias Blüher, Ralf Hoffmann, Glycation Sites of Human Plasma Proteins Are Affected to Different Extents by Hyperglycemic Conditions in Type 2 Diabetes Mellitus Analytical and Bioanalytical Chemistry. ,vol. 406, pp. 5755- 5763 ,(2014) , 10.1007/S00216-014-8018-Y
Feliciano Priego-Capote, Alexander Scherl, Markus Müller, Patrice Waridel, Frédérique Lisacek, Jean-Charles Sanchez, Glycation Isotopic Labeling with 13C-Reducing Sugars for Quantitative Analysis of Glycated Proteins in Human Plasma Molecular & Cellular Proteomics. ,vol. 9, pp. 579- 592 ,(2010) , 10.1074/MCP.M900439-MCP200
Margo P. Cohen, Fuad N. Ziyadeh, Sheldon Chen, Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications. Journal of Laboratory and Clinical Medicine. ,vol. 147, pp. 211- 219 ,(2006) , 10.1016/J.LAB.2005.12.006